Total Payments
$1,141
2024 Payments
$29.66
Companies
16
Transactions
67
Medicare Patients
1,216
Medicare Billing
$125,064
Payment Breakdown by Category
Food & Beverage$1,086 (95.2%)
Other$54.99 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,086 | 64 | 95.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54.99 | 3 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $401.92 | 33 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $119.97 | 6 | $0 (2017) |
| ABBVIE INC. | $119.64 | 6 | $0 (2024) |
| Mallinckrodt LLC | $85.93 | 5 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $80.39 | 1 | $0 (2017) |
| Allergan Inc. | $73.65 | 1 | $0 (2018) |
| GENZYME CORPORATION | $66.97 | 3 | $0 (2017) |
| Acorda Therapeutics, Inc | $54.99 | 3 | $0 (2017) |
| US WorldMeds, LLC | $29.58 | 2 | $0 (2017) |
| NEUROPACE, INC. | $20.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.66 | 1 | ABBVIE INC. ($29.66) |
| 2023 | $51.05 | 3 | ABBVIE INC. ($51.05) |
| 2022 | $18.03 | 1 | ABBVIE INC. ($18.03) |
| 2021 | $361.12 | 31 | Teva Pharmaceuticals USA, Inc. ($340.22) |
| 2020 | $47.70 | 2 | Teva Pharmaceuticals USA, Inc. ($47.70) |
| 2018 | $73.65 | 1 | Allergan Inc. ($73.65) |
| 2017 | $559.79 | 28 | Novartis Pharmaceuticals Corporation ($119.97) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Central Nervous System | ||||||
| 12/02/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Central Nervous System | ||||||
| 11/23/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Central Nervous System | ||||||
| 11/23/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Central Nervous System | ||||||
| 11/10/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Central Nervous System | ||||||
| 10/28/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Central Nervous System | ||||||
| 10/28/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Central Nervous System | ||||||
| 10/28/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: Central Nervous System | ||||||
| 10/07/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Central Nervous System | ||||||
| 09/24/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: Central Nervous System | ||||||
| 09/23/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Central Nervous System | ||||||
| 08/05/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Central Nervous System | ||||||
| 07/22/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Central Nervous System | ||||||
| 07/08/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Central Nervous System | ||||||
| 07/08/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Central Nervous System | ||||||
| 07/02/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Central Nervous System | ||||||
| 06/24/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Central Nervous System | ||||||
| 06/17/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 62 | 71 | $24,628 | $7,289 |
| 2022 | 3 | 85 | 88 | $43,081 | $7,120 |
| 2021 | 13 | 526 | 571 | $261,102 | $56,689 |
| 2020 | 13 | 543 | 609 | $266,192 | $53,966 |
Total Patients
1,216
Total Services
1,339
Medicare Billing
$125,064
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 37 | $11,914 | $3,789 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,620 | $2,474 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,094 | $1,026 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $19,658 | $3,083 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 37 | $17,530 | $2,797 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $5,893 | $1,240 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 142 | $67,160 | $15,185 | 22.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 95 | 95 | $65,900 | $14,058 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 75 | $24,345 | $5,267 | 21.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 22 | $14,301 | $3,521 | 24.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 57 | 61 | $14,345 | $3,061 | 21.3% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 17 | 17 | $12,537 | $2,701 | 21.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 20 | 20 | $12,286 | $2,634 | 21.4% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 23 | 23 | $12,142 | $2,442 | 20.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 22 | 22 | $10,504 | $2,106 | 20.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $10,391 | $1,962 | 18.9% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 35 | 41 | $5,921 | $1,324 | 22.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 13 | $5,915 | $1,224 | 20.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 17 | $5,355 | $1,204 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 128 | 164 | $73,441 | $13,805 | 18.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 78 | 78 | $52,572 | $10,974 | 20.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 48 | 55 | $24,620 | $5,130 | 20.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 64 | 68 | $19,041 | $4,131 | 21.7% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 24 | 24 | $16,640 | $3,453 | 20.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 27 | 27 | $14,564 | $2,966 | 20.4% |
About Dr. Gary Johnson, MD
Dr. Gary Johnson, MD is a Neurology healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841226867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Johnson, MD has received a total of $1,141 in payments from pharmaceutical and medical device companies, with $29.66 received in 2024. These payments were reported across 67 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,086).
As a Medicare-enrolled provider, Johnson has provided services to 1,216 Medicare beneficiaries, totaling 1,339 services with total Medicare billing of $125,064. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Smithfield, RI
- Active Since 06/23/2006
- Last Updated 12/18/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1841226867
Products in Payments
- AUSTEDO (Drug) $387.92
- GILENYA (Drug) $119.97
- ACTHAR (Biological) $85.93
- Dysport 300 U-1 (Drug) $80.39
- BOTOX THERAPEUTIC (Biological) $73.65
- DUOPA (Drug) $66.48
- AMPYRA (Drug) $54.99
- UBRELVY (Drug) $53.16
- AUBAGIO (Drug) $50.71
- MYOBLOC (Biological) $29.58
- RNS System (Device) $20.85
- APTIOM (Drug) $17.29
- LEMTRADA (Drug) $16.26
- Briviact (Drug) $15.54
- NUPLAZID (Drug) $14.21
- COPAXONE (Drug) $14.00
- Zembrace (Drug) $13.50
- Horizant (Drug) $13.30
- TROKENDI XR (Drug) $13.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.